These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 27383479)

  • 41. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples.
    Enyedi MZ; Jaksa G; Pintér L; Sükösd F; Gyuris Z; Hajdu A; Határvölgyi E; Priskin K; Haracska L
    Oncotarget; 2016 Sep; 7(38):61845-61859. PubMed ID: 27533253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations.
    Concolino P; Costella A; Minucci A; Scaglione GL; Santonocito C; Salutari V; Scambia G; Zuppi C; Capoluongo E
    Clin Chim Acta; 2014 Nov; 437():72-7. PubMed ID: 25007954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BRCA Testing by Single-Molecule Molecular Inversion Probes.
    Neveling K; Mensenkamp AR; Derks R; Kwint M; Ouchene H; Steehouwer M; van Lier B; Bosgoed E; Rikken A; Tychon M; Zafeiropoulou D; Castelein S; Hehir-Kwa J; Tjwan Thung D; Hofste T; Lelieveld SH; Bertens SM; Adan IB; Eijkelenboom A; Tops BB; Yntema H; Stokowy T; Knappskog PM; Høberg-Vetti H; Steen VM; Boyle E; Martin B; Ligtenberg MJ; Shendure J; Nelen MR; Hoischen A
    Clin Chem; 2017 Feb; 63(2):503-512. PubMed ID: 27974384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening.
    Park J; Jang W; Chae H; Kim Y; Chi HY; Kim M
    Ann Lab Med; 2016 Mar; 36(2):197-201. PubMed ID: 26709275
    [No Abstract]   [Full Text] [Related]  

  • 47. BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report.
    Pepe F; Pisapia P; Russo G; Nacchio M; Pallante P; Vigliar E; De Angelis C; Insabato L; Bellevicine C; De Placido S; Troncone G; Malapelle U
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations.
    De Leeneer K; Hellemans J; De Schrijver J; Baetens M; Poppe B; Van Criekinge W; De Paepe A; Coucke P; Claes K
    Hum Mutat; 2011 Mar; 32(3):335-44. PubMed ID: 21305653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.
    Dodova RI; Mitkova AV; Dacheva DR; Hadjo LB; Vlahova AI; -Hadjieva MST; Valev SS; Caulevska MM; Popova SD; Popov IE; Dikov TI; Sedloev TA; Ionkov AS; Timcheva KV; Christova SL; Kremensky IM; Mitev VI; Kaneva RP
    BMC Cancer; 2015 Jul; 15():523. PubMed ID: 26183948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis.
    Scaglione GL; Concolino P; De Bonis M; De Paolis E; Minucci A; Ferrandina G; Scambia G; Capoluongo E
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570666
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome.
    Yoo J; Lee GD; Kim JH; Lee SN; Chae H; Han E; Kim Y; Kim M
    Ann Lab Med; 2020 Mar; 40(2):148-154. PubMed ID: 31650731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRACNAC: A
    Kechin A; Boyarskikh U; Borobova V; Khrapov E; Subbotin S; Filipenko M
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068953
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Szczerba E; Kamińska K; Mierzwa T; Misiek M; Kowalewski J; Lewandowska MA
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comprehensive BRCA1/2 NGS pipeline for an immediate Copy Number Variation (CNV) detection in breast and ovarian cancer molecular diagnosis.
    Concolino P; Rizza R; Mignone F; Costella A; Guarino D; Carboni I; Capoluongo E; Santonocito C; Urbani A; Minucci A
    Clin Chim Acta; 2018 May; 480():173-179. PubMed ID: 29458049
    [No Abstract]   [Full Text] [Related]  

  • 55. cutPrimers: A New Tool for Accurate Cutting of Primers from Reads of Targeted Next Generation Sequencing.
    Kechin A; Boyarskikh U; Kel A; Filipenko M
    J Comput Biol; 2017 Nov; 24(11):1138-1143. PubMed ID: 28715235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of a variant detection workflow for BRCA1 and BRCA2 genes and its clinical application based on the Ion Torrent technology.
    Buzolin AL; Moreira CM; Sacramento PR; Oku AY; Fornari ARDS; Antonio DSM; Quaio CRDAC; Baratela WR; Mitne-Neto M
    Hum Genomics; 2017 Jun; 11(1):14. PubMed ID: 28651617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer.
    Kwong A; Chen J; Shin VY; Ho JC; Law FB; Au CH; Chan TL; Ma ES; Ford JM
    Cancer Genet; 2015 Sep; 208(9):448-54. PubMed ID: 26271414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample.
    Rodríguez-Balada M; Roig B; Martorell L; Melé M; Salvat M; Vilella E; Borràs J; Gumà J
    Cancer Genet; 2016 Nov; 209(11):487-492. PubMed ID: 27886673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting.
    Münz M; Ruark E; Renwick A; Ramsay E; Clarke M; Mahamdallie S; Cloke V; Seal S; Strydom A; Lunter G; Rahman N
    Genome Med; 2015 Jul; 7(1):76. PubMed ID: 26315209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.